Efficacy of 5-HT1F agonist versus CGRP-antagonists for treatment of acute migraine: A systematic review and network meta-analysis
Background: Two new classes of drugs approved by USFDA for the treatment of acute migraine are non-peptide Calcitonin Gene-Related Peptide (CGRP) receptor antagonists (rimegepant and ubrogepant) and 5-HT1F receptor agonist lasmiditan. There are no clinical trials comparing these two classes of newer...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Eldaghayes Publisher
2023-02-01
|
| coleção: | National Journal of Physiology, Pharmacy and Pharmacology |
| Assuntos: | |
| Acesso em linha: | http://www.ejmanager.com/fulltextpdf.php?mno=57906 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|